The advent of 5G will impact the way society connects and exploits connectivity, extending mobile data from simple phones to devices of every flavor—cars, bridges, buildings, roads, doorbells, fridges, drones—indeed, anything that either provides or benefits from data. But how well do you understand 5G and will your industry or your organization be impacted?
Gene Quinn discusses the various patent prosecution sourcing models available today, their strengths and weaknesses, and how a thoughtful, coordinated approach to preparation and prosecution of patent applications can stretch budgets without reducing quality. Joining Gene is Donato Pasquariello, Senior Patent Attorney for Ericsson, Jeff Waters, Partner with Cantor Colburn, Brad Lawrence, Partner with Cantor Colburn and Richard Kolar, Head of Services for Derwent, a Clarivate Analytics company.
In this webinar, our panel of experts lay out the blockchain patent landscape and discuss the issues around blockchain patenting and the potential impact on different technology areas, including the patent system itself.
Join Gene Quinn, President and CEO of IPWatchdog, Inc, on Thursday, April 4, 2019, at 12 pm (noon) EDT, for an informative discussion on the all-important topic of information disclosure practices and requirements. Joining Gene will be Jeffrey Waters, Partner Cantor Colburn, and Michael Rau, Director IP Technical Services at Clarivate Analytics.
As a follow-up to the Derwent Top 100 Global Innovators 2018-19 report, we invite you to a webinar featuring notable speakers from Microsoft, Dow, and 3M. The discussion will focus on the ways these industry leaders push boundaries to bring new ideas to market and foster a culture of innovation, and how IP and R&D teams can work together to drive commercial success.
In a recent article, “Trends in Oncology Dealmaking” published in BioPharma Dealmakers, analysts from Clarivate Analytics explored recent trends in oncology deals, and specifically immuno-oncology, which accounted for 32 of the 35 multibillion-dollar oncology licensing deals of the last five years. Join us on May 16 at 11AM EST as we discuss key findings from this article along with research from BioWorld and an insightful patent analysis based on data from the Derwent World Patents Index and the Derwent Patents Citation Index.
This webinar is essential for global intellectual property owners looking to understand the key challenges and opportunities when innovating in the region. Common questions around the integration and analysis of Chinese patent data in the search process will be answered during this action-packed session.
In this panel talk, we will discuss an analysis on Cannabinoids patent filings which will soon be published by Derwent as a case study; using our research as a framework for a wider discussion. Cannabinoids are an active innovation area for both established multi-national patent filers as well as new entrants, as the legalization and decriminalization trend for cannabinoids increases.
Malpractice concerns for patent practitioners are on the rise. As patents become more valuable and the intricacies of patent practice only continue to grow, the opportunity for mistakes with severe consequences are escalating. There is no substitute for being prepared, highly organized and having systems and policies in place to deal with a malpractice event.
Join Gene Quinn on Thursday, September 27, 2018, for a free webinar discussion on the important topic of streamlining the patent prosecution process and stretching a patent budget efficiently. Joining Gene will be Sherry Knowles, Principal with Knowles Intellectual Property Strategies and former Senior Vice President and Chief Patent Counsel at GlaxoSmithKline, and Stuart Recher, Vice President of IP Services for Clarivate Analytics.
This webinar will review how we at Clarivate Analytics are using AI to develop advanced search and analysis capability leveraging the power of the world’s gold standard patent database, Derwent World Patents Index, to complement the work of the professional searcher.
During 2017, 5.6 million patent documents were published globally, with almost 50% of those being in Chinese. With patent data growing in both volume and complexity, precise monitoring and data mining is critical to gain true perspective on your patent landscape.
In this webinar, we will review new biological therapeutic approaches such as CAR-T cell therapies and the challenges they present for patent searchers. We will illustrate how new tools, such as GENESEQ on SequenceBase and Derwent Innovation, can be used to reduce the margin for error during the patent search process, greatly increasing the speed and accuracy of your search for engineered sequences and the assessment of freedom to operate and actual infringement risk.